Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-22T07:02:29.893Z Has data issue: false hasContentIssue false
  • English
  • Français

Growth hormone and physiological responses to clonidine in depression

Published online by Cambridge University Press:  09 July 2009

Cornelius L. E. Katona ,
David Healy ,
Eugene S. Paykel ,
Andreas E. Theodorou ,
Kevin M. Lawrence ,
Andrew Whitehouse ,
Bill White  and
Roger W. Horton
Cornelius L. E. Katona*
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
David Healy
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Eugene S. Paykel
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Andreas E. Theodorou
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Kevin M. Lawrence
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Andrew Whitehouse
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Bill White
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
Roger W. Horton
Affiliation:
Department of Psychiatry, University College and Middlesex School of Medicine, London
*
1Address for correspondence: Professor Cornelius L. E. Katona, Department of Psychiatry, UCMSM, Wolfson Building, Middlesex Hospital, London WIN 8AA.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Clonidine (1·3 μg/kg) was administered to 62 control and 55 depressed patients free of psychoactive drugs for at least 7 days and fasted overnight. Growth hormone (GH), pulse, blood pressure and sedation were measured every 15 min for 1 h before and 2 h after clonidine infusion.

GH response did not differ significantly between control and depressed subjects overall or when divided by sex. The systolic hypotensive and sedative responses were blunted in depressed subjects compared with controls; these effects appeared to be secondary to residual antidepressant drugs since the differences were only significant for those depressed subjects with short drug-free intervals.

No differences between depressed subjects and controls were seen in diastolic hypotensive or bradycardic responses and no differences in GH, cardiovascular or sedative responses were found between endogenous and non-endogenous depressed subjects.

Type
Original Articles
Information
Psychological Medicine , Volume 23 , Issue 1 , February 1993 , pp. 57 - 63
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Al-Damluji, S., Bouloux, P., White, A. & Besser, M. (1990). The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system. Neuroendocrinology 51, 76–81.CrossRefGoogle ScholarPubMed
Amsterdam, J. D., Maislin, G., Skolnick, B., Berwish, N. & Winokur, A. (1989). Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers. Biological Psychiatry 26, 265–278.CrossRefGoogle ScholarPubMed
Ansseau, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.-J. & Franck, G. (1984). Concurrent use of REM latency, dexamethasone suppression, clonidine and apomorphine tests as biological markers of endogenous depression: a pilot study. Psychiatry Research 12, 261–272.CrossRefGoogle ScholarPubMed
Ansseau, M., von Frenckell, R., Cerfontaine, J. L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V. & Legros, J. J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry 153, 65–71.CrossRefGoogle ScholarPubMed
ARC Scientific (1989). Easistat (version 1.09). ARC Scientific: Oxford.Google Scholar
Boyer, P., Davila, M., Schaub, C. & Nassiet, J. (1986). Growth Hormone response to clonidine in depressed states. Psychiatrie et Psychobiologie 1, 189–195.CrossRefGoogle Scholar
Carney, M. W. P., Roth, M. & Garside, R. F. (1965). The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry 140, 659–674.CrossRefGoogle Scholar
Carroll, B. J. (1982). The dexamethasone suppression test for melancholia. British Journal of Psychiatry 140, 292–304.CrossRefGoogle ScholarPubMed
Charney, D. S., Heninger, G. R., Sternberg, D. E., Hafstad, K. M., Giddings, S. & Landis, D. H. (1982). Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy subjects. Archives of General Psychiatry 39, 290–294.CrossRefGoogle ScholarPubMed
Checkley, S. A., Slade, A. P. & Shur, E. (1981). Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry 138, 51–55.CrossRefGoogle ScholarPubMed
Checkley, S. A., Glass, I. B., Thompson, C., Corn, T. & Robinson, P. (1984). The GH response to clonidine in endogenous as compared with reactive depression. Psychological Medicine 14, 773–777.CrossRefGoogle ScholarPubMed
Checkley, S. A., Corn, T. H., Glass, I. B., Burton, S. W. & Burke, C. A. (1986). The responsiveness of central alpha2-adrenoceptors in depression. In The Biology of Depression ed. Deakin, J. F. W.), pp. 100–120. Gaskell: London.Google Scholar
Coppen, A., Abou-Saleh, M. T., Milln, P., Metcalfe, M., Harwood, J. & Bailey, J. (1983). Dexamethasone suppression test in depression and other psychiatric illness. British Journal of Psychiatry 143, 498–504.CrossRefGoogle Scholar
Dolan, R. J. & Calloway, S. P. (1986). The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression. American Journal of Psychiatry 143, 772–774.Google ScholarPubMed
Gil-ad, I., Gurewitz, R., Marcovici, O., Rosenfeld, J. & Laron, Z. (1984). Effect of ageing on human plasma growth hormone response to clonidine. Mechanisms of Ageing and Development 27, 97–100.CrossRefGoogle ScholarPubMed
Glass, I. B., Checkley, S. A., Shur, E. & Dawling, S. (1982). The effect of desipramine upon central adrenergic function in depressed patients. British Journal of Psychiatry 141, 372–376.CrossRefGoogle ScholarPubMed
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.CrossRefGoogle ScholarPubMed
Hoehe, M., Valido, G. & Matussek, N. (1988). Growth hormone, noradrenaline, blood pressure and cortisol responses to clonidine in healthy male volunteers: dose-response relations and reproducibility. Psychoneuroendocrinology 13, 409–418.CrossRefGoogle ScholarPubMed
Katona, C. L. E. & Roth, M. (1985). The dexamethasone suppression test in schizoaffective depression. Journal of Affective Disorders 8, 107–112.CrossRefGoogle Scholar
Lanes, R., Herrera, A., Palacios, A. & Moncada, G. (1983). Decreased secretion of ACTH and cortisol after oral clonidine in normal adults. Metabolism 32, 568–570.CrossRefGoogle ScholarPubMed
Lesch, K. P., Laux, G., Schulte, H. M., Erb, A., Pfuller, H. & Beckmann, M. (1988). Pre- and post-synaptic alpha-adrenergic effects of clonidine in major depressive disorder. Pharmaco-psychiatry 21, 430–431.CrossRefGoogle Scholar
Lowenstein, J. (1980). Clonidine. Annals of Internal Medicine 92, 74–77.CrossRefGoogle ScholarPubMed
Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schröder, H.-Th., Schultes, T. H. & Wasilewski, B. (1980). Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Research 7, 221–227.Google Scholar
Mitchell, P., Smythe, G., Parker, G., Wilhelm, K., Brodaty, H., Boyce, P. & Hickie, I. (1990). Growth hormone and other hormonal responses to clonidine in melancholic and non-melancholic depressed subjects and controls. Psychiatry Research 37, 179–193.CrossRefGoogle Scholar
Paykel, E. S., Hollyman, J. A., Freeling, P. & Sedgwick, P. (1988). Prediction of benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. Journal of Affective Disorders 14, 83–95.CrossRefGoogle Scholar
Schittecatte, M., Charles, G., Machowski, R. & Wilmotte, J. (1989). Tricyclic wash out and growth hormone response to clonidine. British Journal of Psychiatry 154, 858–863.CrossRefGoogle ScholarPubMed
Siever, L. J. & Uhde, T. W. (1984). New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha2-adrenergic agonist clonidine. Biological Psychiatry 19, 131–156.Google Scholar
Spitzer, R. L. & Endicott, J. (1978). Research Diagnostic Criteria for a Selected Group of Functional Disorders (3rd edn). Psychiatric Institute: New York.Google Scholar
World Health Organization (1978). The International Classification of Diseases (9th edn). World Health Organization: Geneva.Google Scholar